Medicare Advantage

Medicare Advantage risk adjustment is facing a sharper enforcement cycle, with HHS OIG audits alleging unsupported diagnosis coding at UnitedHealthcare and Humana plans and DOJ FCA settlements reinforcing that MA coding programs are now a core fraud-and-abuse target, not just a payment-policy dispute. The pressure coincides with Star Ratings headwinds—CMS’ 2027 draft cut points and reward-factor dynamics could reduce future quality bonus revenue—forcing MA plans, delegated risk groups, and VBC providers to rebalance growth strategies around documentation defensibility, audit readiness, and measurable outcomes rather than coding intensity alone. For ACOs and provider groups taking downside risk, the signal is clear: MA economics are tightening simultaneously on revenue integrity and quality performance, increasing the strategic value of compliant risk capture, prospective care management, and contract terms that protect providers from retrospective recoupment exposure (HHS OIG audits; 2027 Star Ratings cut points).